These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30105657)

  • 41. Safety of high-dose micafungin for patients with hematological diseases.
    Yamazaki S; Nakamura F; Yoshimi A; Ichikawa M; Nannya Y; Kurokawa M
    Leuk Lymphoma; 2014 Nov; 55(11):2572-6. PubMed ID: 24460099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.
    Huang X; Chen H; Han M; Zou P; Wu D; Lai Y; Huang H; Chen X; Liu T; Zhu H; Wang J; Hu J
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1509-16. PubMed ID: 22469884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients.
    Saliba F; Pascher A; Cointault O; Laterre PF; Cervera C; De Waele JJ; Cillo U; Langer RM; Lugano M; Göran-Ericzon B; Phillips S; Tweddle L; Karas A; Brown M; Fischer L; ;
    Clin Infect Dis; 2015 Apr; 60(7):997-1006. PubMed ID: 25520332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Micafungin.
    Jarvis B; Figgitt DP; Scott LJ
    Drugs; 2004; 64(9):969-82; discussion 983-4. PubMed ID: 15101786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States.
    Yang H; Chaudhari P; Zhou ZY; Wu EQ; Patel C; Horn DL
    Appl Health Econ Health Policy; 2014 Feb; 12(1):85-93. PubMed ID: 24385260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bridging antifungal prophylaxis with 50 mg or 100 mg micafungin in allogeneic stem cell transplantation: A retrospective analysis.
    Rothe A; Claßen A; Carney J; Hallek M; Mellinghoff SC; Scheid C; Holtick U; von Bergwelt-Baildon M
    Eur J Haematol; 2020 Apr; 104(4):291-298. PubMed ID: 31856310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacodynamics and pharmacokinetics of micafungin in adults, children and neonate].
    Catalán-González M; Carlos Montejo-González J
    Rev Iberoam Micol; 2009 Mar; 26(1):23-34. PubMed ID: 19463274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biological Properties and Analytical Methods for Micafungin: A Critical Review.
    Marena GD; Dos Santos Ramos MA; Bauab TM; Chorilli M
    Crit Rev Anal Chem; 2021; 51(4):312-328. PubMed ID: 32064916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections.
    Scott LJ
    Drugs; 2012 Nov; 72(16):2141-65. PubMed ID: 23083111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Micafungin may be safely administered as outpatient parenteral antimicrobial therapy for chronic pulmonary aspergillosis.
    Otu AA; Bongomin F; Bazaz R; Harris C; Denning DW; Kosmidis C
    Mycoses; 2019 Feb; 62(2):152-156. PubMed ID: 30267594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic Candida infections in the UK.
    Sidhu MK; van Engen AK; Kleintjens J; Schoeman O; Palazzo M
    Curr Med Res Opin; 2009 Aug; 25(8):2049-59. PubMed ID: 19575628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Micafungin as antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: results of different dosage levels in clinical practice.
    Langebrake C; Rohde H; Lellek H; Wolschke C; Kröger NM
    Clin Transplant; 2014 Mar; 28(3):286-91. PubMed ID: 24479680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Micafungin: A Review in the Prophylaxis and Treatment of Invasive Candida Infections in Paediatric Patients.
    Scott LJ
    Paediatr Drugs; 2017 Feb; 19(1):81-90. PubMed ID: 28083856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patients at high risk of invasive fungal infections: when and how to treat.
    Rüping MJ; Vehreschild JJ; Cornely OA
    Drugs; 2008; 68(14):1941-62. PubMed ID: 18778118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
    Maertens JA; Raad II; Marr KA; Patterson TF; Kontoyiannis DP; Cornely OA; Bow EJ; Rahav G; Neofytos D; Aoun M; Baddley JW; Giladi M; Heinz WJ; Herbrecht R; Hope W; Karthaus M; Lee DG; Lortholary O; Morrison VA; Oren I; Selleslag D; Shoham S; Thompson GR; Lee M; Maher RM; Schmitt-Hoffmann AH; Zeiher B; Ullmann AJ
    Lancet; 2016 Feb; 387(10020):760-9. PubMed ID: 26684607
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.
    Wang Y; Xie J; Xing Y; Chen L; Li Y; Meng T; Dong W; Wang X; Dong Y
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Invasive fungal infections: the challenge continues.
    Gullo A
    Drugs; 2009; 69 Suppl 1():65-73. PubMed ID: 19877737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
    Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
    Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Micafungin treatment and eradication of candiduria among hospitalized patients.
    Gabardi S; Martin S; Sura M; Mohammed A; Golan Y
    Int Urol Nephrol; 2016 Nov; 48(11):1881-1885. PubMed ID: 27587066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.